10-KT

SEC Filing Details

Document Details

Form
Filing Date
Mar 7, 2018
Document Date
Oct 31, 2017
Form Description
Annual transition reports filed rule 13a-10 or 15d-10 of the Securities Exchange Act
Filing Group
Annual Filings
Company
Opiant Pharmaceuticals, Inc.
Issuer
Opiant Pharmaceuticals, Inc.